Target intelligence / Profile preview

mRNA turnover 4 homolog pseudogene

Molecular classification
Pseudogene, Long non-coding RNA (lncRNA; pseudogenes may be transcribed as lncRNAs)
01

Overview

The mRNA turnover 4 homolog pseudogene is a genomic sequence that resembles the gene encoding a protein involved in mRNA turnover, but carries mutations such as stop codons, frameshifts, or deletions which prevent it from producing a functional protein[1][3][6]. Pseudogenes like this may sometimes be transcribed into RNA and can participate in regulatory networks, for example, by acting as RNA sponges for microRNAs and modulating the expression of their parental genes[6][7]. However, most pseudogenes, including this one, have limited or no proven biological function and are not considered therapeutic targets in biomedical research[1][3][6]. The designation "pseudogene" signals it is generally non-functional at the protein level and not a receptor, enzyme, transporter, or transcription factor. It is not a candidate for therapeutic intervention[1][3][6].

02

Biological functions

Potential regulatory role at the RNA level, such as competing for microRNA binding (acting as a competing endogenous RNA, ceRNA)Modulation of parent gene expressionMost pseudogenes—including this one—are generally biologically inconsequential and do not directly participate in canonical cell signaling, transport, or enzymatic reactions
03

Disease associations

Possible involvement in gene regulation dysfunction, but *no established direct role* in specific diseases for this pseudogenePseudogenes can sometimes act as gene regulators, affecting processes like cancer or development, but this is not well-characterized for mRNA turnover 4 homolog pseudogene

Beyond the preview

Go deeper on mRNA turnover 4 homolog pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mRNA turnover 4 homolog pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call